Cellebrite
CLBT
78 hedge funds and large institutions have $305M invested in Cellebrite in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 4 closing their positions.
500% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 4
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
32% more funds holding
Funds holding: 59 → 78 (+19)
23% more capital invested
Capital invested by funds: $249M → $305M (+$56.3M)
10% more call options, than puts
Call options by funds: $1.96M | Put options by funds: $1.79M
0.22% more ownership
Funds ownership: 21.56% → 21.78% (+0.22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.42M |
| 2 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$2.25M |
| 3 |
VC
Voss Capital
Houston,
Texas
|
+$2.01M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.72M |
| 5 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$4.2M |
| 2 |
IP
Isomer Partners
New York
|
-$2.57M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$2.49M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$821K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$666K |
CLBT Hedge Fund Activity: Q2 2023 in Review
78 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q2 2023, worth a combined $305M — up 23% from $249M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CLBT positions and 4 closed out — a net gain of 20 holders — while 24 added to existing stakes and 16 trimmed.
The largest buyer was Nine Ten Capital Management, opening a new position worth an estimated $2.42M. The largest seller was Light Street Capital Management, cutting an estimated $4.2M.
- 78 institutional investors held Cellebrite (CLBT) as of Q2 2023, up from 59 in Q1 2023.
- Funds reported $305M of Cellebrite stock for Q2 2023, up 23% quarter-over-quarter.
- 24 funds opened new Cellebrite positions in Q2 2023 and 4 closed out, a net change of +20 holders.
- The largest Cellebrite buyer in Q2 2023 was Nine Ten Capital Management, an estimated $2.42M added.
- The largest Cellebrite seller in Q2 2023 was Light Street Capital Management, an estimated $4.2M sold.
Based on aggregated 13F filings for Q2 2023.